We are a preclinical-stage biotechnology spin-off company from Chulalongkorn University, focusing on the development of novel gene-edited immune cell products for cancer treatment.
Headquarters:
Thailand
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2022 (4 years)
Address:
189/68 LADPRAO; 26 JOMPON JATUJAK; BANGKOK, BANGKOK 10900, TH
Employees by Department
Key Decision Makers
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has CELLMIDI been operating for?
- What is the funding status of CELLMIDI?
- Where is CELLMIDI's headquarter?
- What CELLMIDI's spending power?
- Does CELLMIDI have a presence in the domain it operates in?

